Design and Objectives of the ELCIE Clinical Trial

Effects of rhLactoferrin on Chronic Inflammation in the Elderly: Design and Objectives of the ELCIE Clinical Trial We have previously introduced an ongoing clinical study, headed by principal investigator Jeremy Walston, MD,  Johns Hopkins School of Medicine, aimed at finding out if recombinant human lactoferrin (rhLactoferrin) produced from Ventria Bioscience’s ExpressTec biologic manufacturing system may […]

0 comments

Breastmilk and the developing infant brain

In a previous post, we discussed how the composition of human breastmilk protects infant health and aids in the early development of the gut and immune system. We also talked about how some of those beneficial properties can be isolated to specific milk proteins that can now be produced affordably, in high yield, for clinical […]

0 comments

Studying a potential new insulin analog for diabetes therapy

Toward a better insulin analog: improving product yield enables scientific study of potential new diabetes therapy. Daily injections of the pancreatic peptide-hormone insulin are essential to life for many people living with type 1 or advanced type 2 diabetes. While therapeutic insulin was originally available only by purifying it from animal sources, in 1982 a […]

0 comments

Clinical study: can a protein derived from breastmilk palliate symptoms of inflammation in the elderly?

Through the process of natural selection, the components of mammalian breastmilk have been shaped over the course of millions of years. For each species of mammal, breastmilk provides not only the nutrients that neonates and infants require for proper growth and development outside of the womb, but also a host of components that protect the […]

0 comments

Ventria Bioscience partners with BMGF to address pediatric diarrhea in the developing world

In our last post, we discussed results from a re-analysis of the Global Enteric Multicenter Study (GEMS), which found that the key pathogens responsible for nearly 80% of worldwide cases of pediatric diarrhea are Shigella spp, rotavirus, adenovirus 40/41, heat-stable enterotoxigenic E. coli (ETEC), Cryptosporidium spp, and Campylobacter spp. Previously, we also discussed a study, […]

0 comments

Causes of diarrhea in children: The Global Enteric Multicenter Study (GEMS)

Worldwide, diarrheal diseases are the second leading cause of death in children younger than 5 years of age, killing approximately half a million children every year. The causes of diarrhea are multifold, and public health efforts to address this challenge require reliable, consistent estimates of pathogen burden. The Global Enteric Multicenter Study (GEMS) was a […]

0 comments

Protecting American scientific innovation for the greater good

In 2013, US Customs officers discovered something suspicious—packets of rice seeds—in baggage belonging to Chinese travelers heading home after a visit to the U.S. It turns out that the travelers were employees of a Chinese crop-research institute, and had been handed the seeds in an act of attempted industrial espionage. Ventria Bioscience CEO Scott Deeter […]

0 comments

Alleviating symptoms of pediatric diarrhea in developing countries

As you’ll learn if you spend enough time reading our blog and our website, Ventria Bioscience has a couple of different thrusts with regard to the use of our ExpressTec technology. On the one hand, ExpressTec is a platform technology—in other words, it’s a powerful and valuable tool for producing high yields of high-quality, highly […]

0 comments

Mechanism of Action of rhLactoferrin in Inflammatory Bowel Disease (IBD)

As we said in our opening post, our intention for this blog is to share news and analysis related to plant-based recombinant expression systems and how our work at Ventria Bioscience fits into the broader context of global public health. To kick things off, we’re going to take a look back at a recent journal […]

0 comments

Welcome to In Context

Ventria Bioscience is proud to launch our completely redesigned website.

0 comments